Keynote Speakers
John Palma
Chief Medical Officer, Roche Sequencing Solutions | 
Bob Carter
Professor and Chief of Neurosurgery, Massachusetts General Hospital, Harvard Medical School | 
Stefan Momma
Group Leader, University Hospital Frankfurt | .png)
Gyongyi Szabo
Professor & Vice Chair for Research, Department of Medicine, University of Massachusetts Medical School | 
Joshua Levin
Senior Scientist/Group Leader, The Broad Institute of MIT and Harvard | 
Shannon Stott
Assistant Professor, Massachusetts General Hospital & Harvard Medical School |
|
Chwee Teck Lim
Provost's Chair Professor, Principal Investigator, Mechanobiology Institute, National University of Singapore | 
Saumya Das
Assistant Professor in Medicine, Beth Israel Deaconess Medical Center and Mass General Hospital | 
Xandra Breakefield
Professor, Mass General Hospital (MGH)/Harvard Medical School | 
Frank Slack
Director, Institute for RNA Medicine, Beth Israel Deaconess Medical Center Cancer Center/Harvard Medical School | 
Shana Kelley
Professor, University of Toronto | 
Peter Quesenberry
Professor of Medicine, The Warren Alpert Medical School of Brown University | 
Steve Soper
Foundation Distinguished Professor, Director, Center of BioModular Multi-scale System for Precision Medicine, The University of Kansas | 
Clark Chen
Co-Director, University of California-San Diego | 
Phil Stephens
Chief Scientific Officer, Foundation Medicine |
Overview
|
The 3rd. Annual SELECTBIO Circulating Biomarkers World Congress 2016 brings together academic researchers as well as industry participants to present and discuss the most up-to-date research and commercial activities in the translation of various circulating biomarker classes towards the clinic.
This Congress discusses Nucleic Acid-based Biomarkers, Protein-based Biomarkers, Extracellular Vesicle (EV)-based Biomarkers (contained within exosomes and microvesicles), and Circulating Tumor Cell (CTC)-based Biomarkers.
|
|
One of the conference tracks focuses on Liquid Biopsies as the fields of Circulating Biomarkers and Liquid Biopsy development are converging and the various classes of Circulating Biomarkers may be developed into liquid biopsies for cancer and several other disease classes. A co-located exhibit hall features companies developing technologies and products for the complete workflow from sample isolation, preparation, through data analysis. Conference delegates receive access to all three co-located conference tracks, can mix-and-match presentations from all three tracks thereby maximizing the conference experience, and can network with delegates from the various co-located tracks and exhibition.
Agenda and Information for:
|
|
|
|
|
Corporate Sponsors
|
Media Sponsors
|
|
Networking
|
|
|
|
|
|
|
Add to Calendar ▼2016-03-21 00:00:002016-03-22 00:00:00Europe/LondonCirculating Biomarkers World Congress 2016Circulating Biomarkers World Congress 2016 in Boston, USABoston, USASELECTBIOenquiries@selectbiosciences.com
Liquid Biopsy Slide Deck
